Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Gutmann

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Oncogene|July 26, 2003
Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous miceD H Gutmann, E Winkeler, O Kabbarah, et al.
Nature|April 23, 1992
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patientsT N Basu, D H Gutmann, J A Fletcher, et al.
Journal of Neuroscience Research|January 15, 1996
Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemiaM J Giordano, D K Mahadeo, Y Y He, et al.
Neurology|January 13, 2006
Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytomaM K Sharma, M A Watson, M Lyman, et al.
Human Pathology|August 19, 1999
Molecular analysis of malignant triton tumorsB L Strauss, D H Gutmann, L P Dehner, et al.
Human Molecular Genetics|June 22, 2000
The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrateD R Scoles, D P Huynh, M S Chen, et al.
Human Molecular Genetics|April 4, 2001
The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motilityD H Gutmann, C A Haipek, S P Burke, et al.
Neuropathology and Applied Neurobiology|July 1, 2020
Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migrationJ S Nix, M Yuan, E L Imada, et al.
Oncogene|October 5, 2010
Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancerY Zhan, N Modi, A M Stewart, et al.
The American Journal of Pathology|March 1, 1994
Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cellT Nakamura, T Nemoto, M Arai, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Oncogene|July 26, 2003
Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous miceD H Gutmann, E Winkeler, O Kabbarah, et al.
Nature|April 23, 1992
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patientsT N Basu, D H Gutmann, J A Fletcher, et al.
Journal of Neuroscience Research|January 15, 1996
Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemiaM J Giordano, D K Mahadeo, Y Y He, et al.
Neurology|January 13, 2006
Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytomaM K Sharma, M A Watson, M Lyman, et al.
Human Pathology|August 19, 1999
Molecular analysis of malignant triton tumorsB L Strauss, D H Gutmann, L P Dehner, et al.
Human Molecular Genetics|June 22, 2000
The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrateD R Scoles, D P Huynh, M S Chen, et al.
Human Molecular Genetics|April 4, 2001
The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motilityD H Gutmann, C A Haipek, S P Burke, et al.
Neuropathology and Applied Neurobiology|July 1, 2020
Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migrationJ S Nix, M Yuan, E L Imada, et al.
Oncogene|October 5, 2010
Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancerY Zhan, N Modi, A M Stewart, et al.
The American Journal of Pathology|March 1, 1994
Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cellT Nakamura, T Nemoto, M Arai, et al.
Pageof 13